BCL2 and B-cell chronic lymphocytic leukemia: Further genome-, epigenome-, and transcriptome-wide studies, preferably coupled with functional readout will be essential to achieve a deepened understanding of key mechanisms orchestrating the interplay between various CLL compartments driving resistance to targeted Bcl2 inhibition.